Impact ledger
PTC Therapeutics, Inc. (PTCT)
4 events mapped to this ticker since 2026-06-12.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-29 | Event | Increased competitive pressure in the Friedreich's ataxia market, potential erosion of future market share for existing or pipeline therapies. | Bearish | 3-12m | 0.40 |
| 2026-06-26 | Event | Indirect competitive pressure in Duchenne muscular dystrophy (DMD) market. Deramiocel approval could impact market share for existing DMD therapies. | watch | 1-3m | 0.40 |
| 2026-06-17 | Event | Competitive landscape in Huntington's Disease. Potential for a new entrant (AMT-130) to impact future market share or pricing dynamics if PTC Therapeutics has a competing or pipeline asset. | watch | 3-12m | 0.30 |
| 2026-06-12 | Event | Increased M&A activity in rare diseases/specialty pharmaceuticals. While PTC Therapeutics is not directly in HAE, the acquisition of a rare disease company like KalVista by a larger pharmaceutical firm could signal a broader trend of consolidation or increased valuation for companies with specialize | watch | 1-3m | 0.20 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for PTCT, start a trial or view the PTCT entity page.